A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Attached please find the 0617 newsletter for the month of september. Request pdf variation of cardiac contours using different heart definitions for nsclc patients enrolled on rtog 0617 purposeobjectives in lung cancer radiation therapy, excess heart dose. Variation of cardiac contours using different heart.
Heart dose is an independent dosimetric predictor of overall. Nrg oncology radiation therapy oncology group rtog oxford. Form revision notice rtog 0617 form revision rtog 0617 phase iii nsclc the following form for this study has been revised. Radiotherapy dose and fractionation for stage iii nsclc the lancet. Within this trial, patients with nonsmallcell lung cancer nsclc were. Attached please find the 0617 newsletter for the months of february and march. Our trial rtog 0617 was designed to establish whether a 74 gy dose was better than a 60 gy dose and whether. Regards, treena rtog 0617 newsletter september 2009. New cetuximab investigator brochure now available on the website. Rtog 0617ncctg n0628calgb 30609ecog r0617, a randomized phase iii.
The radiation therapy oncology group rtog 0617 study 1 was an intergroup phase 3 trial that randomized patients with unresectable stage iii nonsmallcell lung cancer nsclc to 1 of 4 treatment arms in a 2. Primary analysis of the phase ii component of a phase iii dose intensification study using threedimensional conformal radiation therapy and concurrent chemotherapy for. Regards, treena rtog 0617 newsletter feb march 2010. October 29, 2010 1818 market street, suite 1600 includes amendments 17. Therefore, the finding of rtog 0617 that heartv5 is a major prognostic factor. Standard versus highdose chemoradiotherapy with or without cetuximab for unresectable stage iii nonsmallcell lung cancer. Bms, imclone andor nci safety reports for cetuximab. Pdf primary analysis of the phase ii component of a. Early tumor and nodal response in patients with locally advanced nonsmall cell lung. The longterm results of rtog 0617 3d crt or imrt established a median overall survival of 28. Attached please find the 0617 newsletter for the month of july.
Nrgalias broadcasts rtog clinical trials protocol table. Comments on medscape are moderated and should be professional in tone and on topic. Publications home of jama and the specialty journals of. Rtog is funded by national cancer institute grant numbers. This project was supported by grants u10ca21661, u10ca180822, u10 ca37422. Sites can download a copy of the updated protocol at.
311 1050 1061 273 80 78 240 1316 446 432 715 1215 1405 738 615 283 281 774 462 174 736 576 937 1132 234 942 286 14 150 745 1401 243 996 122 670 879 1081 1165 800 227